Allergan is the fastest growing pharma company around, and Cramer sees a ton of catalysts moving forward, the ”Mad Money” host said Thursday.
“I like Allergan not just because it knows how to make people look good,” he said, “but because it knows how to make its business grow in a way that's both smart and sustainable.”
The company reported a terrific quarter Thursday morning, posting a 2 cent earnings beat off a 90 cent basis and in-line revenues. It also raised full-year guidance.
Despite those numbers, the stock got slammed. That’s because when you are the fastest growing pharmaceutical, you need to deliver a “flawless” quarter and raise guidance a lot, Cramer said.
But thanks to his robust pipeline, he thinks the stock could be flying again in no time.
To dig deeper into the company’s prospects, Cramer spoke with CEO David Pyott. Watch the video to see the full interview.
Call Cramer: 1-800-743-CNBC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website? email@example.com